Cross-sectional Analysis of Exome Sequencing Diagnosis in Patients with Neurologic Phenotypes Facing Barriers to Clinical Testing (P1-1.009)
This study set out to assess the efficacy of Exome Sequencing (ES) in patients with primary neurologic phenotypes who were unable to pursue clinical testing due to various barriers including insurance.
Authors
- Kathie J. Ngo (ORCID: https://orcid.org/0000-0002-2092-410X)
- Clara Lajonchere (ORCID: https://orcid.org/0000-0002-3190-4606)
- Brent L. Fogel (ORCID: https://orcid.org/0000-0001-9831-1576)
- Sonya Watson (ORCID: https://orcid.org/0009-0002-1461-6829)
- Hannah Stevens (ORCID: https://orcid.org/0000-0003-3394-9768)
- Darice Y. Wong
Institutions
- UCLA Health (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210517
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00